Medical Advisory - Interim Eligibility Criteria for Publicly-Funded Tubersol

Released February 17, 2017

​Issued by: M. Mustafa Hirji, MD, MPH, FRCPC Associate Medical Officer of Health​

The Ministry of Health and Long-Term Care is revising the eligibility criteria for the publicly-funded use of tuberculin skin test (TST) solution (Tubersol®). As part of the ongoing revision, the Ministry has created interim guidelines to determine a client’s eligibility for publicly-funded supply of Tubersol.

Interim Eligibility Criteria

Clients meeting the following criteria are eligible for publicly-funded Tubersol within Ontario:

  • Contacts of cases of active Tuberculosis
  • Tests deemed to be “medically necessary” by the client’s physician or nurse practitioner, based on level of risk as identified in the Canadian Tuberculosis Standards, 7th edition 
  • Clients under the age of 65 who are entering long-term care facilities. Note: Screening via TST is not recommended for clients over the age of 65; instead a chest x-ray is recommended
  • When required by an educational institution for admission or continuation in a day care of pre-school program, or a program of study in a school, community college, university or other educational institution

In addition, publicly-funded Tubersol may only be used for the above reasons if the client is OHIP-insured.

Uninsured Testing

TST testing and completion of an immunization status report is not insured (meaning the patient is responsible for paying for both the completion of the form and the test) when

  • Requested solely as a condition for obtaining employment
  • Required by an employer on an annual or other periodic basis
  • Provided to an uninsured person

When uninsured testing is performed, the testing solution should be purchased by a health care provider and sold to the patient at a direct cost, or acquired by the patient from the pharmacy via prescription provided by a physician or nurse practitioner.

More information related to OHIP insured TST is available online​.

For further information, please contact NRPH, Vaccine Preventable Disease program at 1-888-505-6074 or 905-688-8248 ext. 7425 Monday to Friday 8:30 a.m. to 4:30 p.m.​


Page Feedback Did you find what you were looking for today?